Population and Public Health

QuantHealth cofounder and CEO Orr Inbar discusses how using artificial intelligence for clinical trial simulations can help solve challenges often seen by patients, researchers and the pharmaceutical industry when studying a new drug.

Dr. Raghav Murali-Ganesh, cofounder and CEO of Osara Health, discusses the rise of cancer diagnosis thanks to diagnostic technologies and tools, advances in patient treatments and how Osara advances positive behavioral transformation.  

Leah Binder, president and CEO at the Leapfrog Group, discusses the finalized Patient Safety Structural Measure, which will be implemented in the government's fiscal year 2025, and how it hard-wires patient safety as a top priority in hospitals.

Kauvery Hospital founder Dr Manivannan Selvaraj recalls how their hospital embarked on a digital transformation over two decades ago.

Children's Health Alliance senior director of population health Julie Harris discusses how real-time performance metrics can give providers more information at the point of care and reduce their burdens.  

Hal Wolf, HIMSS president and CEO, discusses the possible influence that conversations at HIMSS24 between international healthcare leaders could have on healthcare technology policy development in the EU and other regions.

Jerry Shultz, Lightbeam Health Solutions' president, says the company's AI identifies COPD patients who need personalized interventions, reducing readmissions and realizing millions of dollars in savings for clients.

Sanofi head of organization capability and transformation, Felix Lee, discusses how the pharma giant leverages digital therapeutics company DarioHealth to complement its drug offerings and enhance patient care and self-management.

Meg Barron, managing director of engagement and outreach at Peterson Health Technology Institute, highlights how the organization independently evaluates digital health offerings and its recent report on digital musculoskeletal solutions.

Mark Polyak, president of global data management at IPSOS, says LLMs can "talk" to patients about administrative tasks like scheduling, but bias and model compatibility must be addressed before clinical deployments.